Shares of Equillium, a pharmaceutical company valued at $27.7 million, surged over 10% on Thursday, June 13, following the announcement of its upcoming inclusion in the Russell Microcap Index starting July 1. Details On Thursday, Equillium’s stock price increased by 10.5% on the Nasdaq, closing at $0.79 per share. However,…